✦ LIBER ✦

A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo an Outpatients with Major Depression

✍ Scribed by Maurizio Fava; Jay D. Amsterdam; Joseph A. Deltito; Carl Salzman; Michael Schwaller; David L. Dunner

Book ID: 110418665
Publisher: American Academy of Clinical Psychiatrists
Year: 1998
Tongue: English
Weight: 478 KB
Volume: 10
Category: Article
ISSN: 1040-1237
DOI: 10.1023/a:1022337927842

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sulpiride and placebo in depressed elder

Sulpiride and placebo in depressed elderly outpatients: A double-blind study

✍ Sirkka-Liisa Kivelä; Erkki Lehtomäki 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 2 views

In a controlled double-blind study, sulpiride 10G200mg daily or placebo was administered over a five-month period to 22 and 24 depressive elderly outpatients. The majority of the patinets in both groups were diagnosed as suffering from relatively mild degrees of depression, i.e. from dysthymic disor

Tianeptine and fluoxetine in major depre

Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study

✍ Vladimir Novotny; Frantisek Faltus 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

In a 6-week, multicentre, randomised, double-blind controlled study, tianeptine (37.5 mg/day) and fluoxetine (20 mg/day) were compared for efficacy and safety in 178 patients with major depression. No significant difference was shown between the two drugs, either in terms of efficacy (MADRS, CGI, CO

Double-blind comparison of citalopram an

Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia

✍ Joseph Mendels; Ari Kiev; Louis F. Fabre 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## This multicenter study compared the efficacy and safety of citalopram and placebo in a population of moderately to severely depressed patients with melancholia. This randomized, double-blind, parallel-group study compared citalopram (flexible dose; 20-80 mg/day) with placebo in 180 psychiatric ou

A double-blind comparative study of sert

A double-blind comparative study of sertraline and amitriptyline in outpatients with major depressive episodes

✍ G. Bersani; V. Rapisarda; N. Ciani; A. Bertolino; G. Sorge 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Paroxetine controlled-release formulatio

Paroxetine controlled-release formulation in the treatment of major depressive disorder: A randomized, double-blind, placebo-controlled study in Japan and Korea

✍ Teruhiko Higuchi; Jin Pyo Hong; Hee-Yeon Jung; Yoshinori Watanabe; Taro Kunitomi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Tianeptine and paroxetine in major depre

Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study

✍ Jean Pierre Lepine; Carlo Altamura; Marc Ansseau; Jose Luis Ayuso Gutierrez; Ist 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Tianeptine (37.5 mg/day) and paroxetine (20 mg/day) were compared in a population of depressive patients without past or current history of co-morbid anxiety and/or important anxiolytic treatment. In a 6-week, double blind trial, the special focus was on anxious symptoms.Both drugs showed good effic